Head of Sales - US Oncology

The Role Moderna continues to expand its innovative mRNA platform, unlocking new applications across diseases and therapeutic areas. As the company advances its oncology pipeline, including a personalized mRNA therapy intismeran autogene in collaboration with Merck, this role will play a critical part in launching Moderna’s first commercial therapeutic into the oncology market. Moderna is seeking a Head of Sales, Oncology, who will establish, lead, and scale the U.S. Oncology Sales organization and drive field strategy and execution for a co‑promoted solid tumor oncology asset operating within a joint commercialization and governance model.

• Establish and lead the U.S. Oncology Sales organization, including field force design, operating model, launch execution, performance management, and long‑range capability build.
• Lead through regional sales leaders and/or sales managers to deliver national oncology launch objectives and sales performance.
• Serve as the senior accountable sales leader for U.S. Oncology within the co‑commercialization model, partnering with Marketing, Market Access, Medical, Analytics, and Alliance leadership to shape and execute launch strategy.
• Own sales resource planning, territory design, field KPIs, incentive input, and executional priorities for the U.S. Oncology sales organization.
• Motivate, manage and develop the skill sets and overall performance of the sales representatives in their respective geographies.
• Own national sales performance for solid tumor indications, including quarterly sales targets, annual growth goals, account penetration and depth, site activation strategy and execution, regimen adoption and sequencing strategy, pull‑through in competitive IO and combo landscapes, and translating joint brand and medical strategy into clear field execution priorities tailored to tumor type and line of therapy.
• Serve as the primary U.S. field sales interface with the alliance partner’s oncology sales leadership.
• Drive alignment on account targeting, SOV, call plans (shared vs. owned accounts), messaging within approved label and promotional boundaries, field KPIs, incentives, and performance reporting.
• Represent Sales in Joint Steering Committee (JSC) and sub‑team governance forums, escalating and resolving executional issues.
• Lead pre‑launch and launch readiness for solid tumor indications, including oncology‑appropriate territory design (IDN, center, and KOL‑weighted), recruiting and onboarding of experienced oncology reps, joint training with alliance partner (MOA, data, regimen positioning), and ensuring seamless coordination with Medical, Marketing, and Market Access on launch execution and post‑launch optimization.
• Ensure field teams effectively navigate multidisciplinary decision making (oncologists, pharmacists, tumor boards), pathway inclusion, sequencing, and combination adoption, and effectively navigate access and reimbursement barriers common in oncology.

• 12+ years of biopharma commercial experience with deep oncology focus, including ≥7 years in oncology sales leadership.
• National or senior regional leadership experience.
• Proven track record of solid tumor launches (competitive or first‑in‑class), alliance, co‑promotion, or matrixed commercial models.
• Strong understanding of oncology account ecosystems and KOL dynamics, regimen‑based adoption and sequencing, market access and pathway dynamics in oncology.
• Experience in IO, targeted therapy, or combination regimens strongly preferred.
• Strong familiarity with oncology market dynamics, IDNs, and community GPO ecosystems.
• Knowledge of oncology‑specific datasets covering market landscape, competitive intelligence, real‑world product utilization, prescription behavior, etc.

• Oncology‑credibility with ability to influence senior external and internal stakeholders.
• Strong alliance mindset; able to lead through shared ownership and complexity.
• Data‑driven, execution‑focused, and comfortable making trade‑offs in key decisions.
• Talent magnet with a strong coaching and development philosophy.
• Strong expertise in oncology launches, particularly novel therapeutics, with an…